Shane Bowen
Technik-/Wissenschafts-/F&E-Leiter bei STANDARD BIOTOOLS INC.
Aktive Positionen von Shane Bowen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| STANDARD BIOTOOLS INC. | Technik-/Wissenschafts-/F&E-Leiter | 05.01.2024 | - |
Palamedrix, Inc.
 Palamedrix, Inc. Miscellaneous Commercial ServicesCommercial Services Part of SomaLogic, Inc., Palamedrix, Inc. engages in leveraging DNA nanotechnology for revolutionary advancements in life science and medicine. The company is based in La Jolla, CA. The company was founded by Shane Bowen, Paul W. K. Rothemund, Ashwin Gopinath. Shane Bowen has been the CEO since incorporation. Palamedrix was acquired by SomaLogic, Inc. on September 30, 2022 for $52.50 million. | Vorstandsvorsitzender | - | - |
| Gründer | - | - | |
| Präsident | - | - |
Karriereverlauf von Shane Bowen
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Chief Executive Officer | 1 |
| Founder | 1 |
| President | 1 |
Sektoral
| Commercial Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| STANDARD BIOTOOLS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Palamedrix, Inc.
Palamedrix, Inc. Miscellaneous Commercial ServicesCommercial Services Part of SomaLogic, Inc., Palamedrix, Inc. engages in leveraging DNA nanotechnology for revolutionary advancements in life science and medicine. The company is based in La Jolla, CA. The company was founded by Shane Bowen, Paul W. K. Rothemund, Ashwin Gopinath. Shane Bowen has been the CEO since incorporation. Palamedrix was acquired by SomaLogic, Inc. on September 30, 2022 for $52.50 million. | Commercial Services |
- Börse
- Insiders
- Shane Bowen
- Erfahrung
